Prognostic role and clinicopathological features of SMAD4 gene mutation in colorectal cancer: a systematic review and meta-analysis

BACKGROUND: Approximately 5.0–24.2% of colorectal cancers (CRCs) have inactivating mutations in SMAD4, making it one of the frequently mutated genes in CRC. We thus carried out a comprehensive system review and meta-analysis investigating the prognostic significance and clinicopathological features...

Descripción completa

Detalles Bibliográficos
Autores principales: Fang, Tian, Liang, Tingting, Wang, Yizhuo, Wu, Haitao, Liu, Shuhan, Xie, Linying, Liang, Jiaying, Wang, Chang, Tan, Yehui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8299661/
https://www.ncbi.nlm.nih.gov/pubmed/34301194
http://dx.doi.org/10.1186/s12876-021-01864-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8299661/
https://www.ncbi.nlm.nih.gov/pubmed/34301194
http://dx.doi.org/10.1186/s12876-021-01864-9

Ejemplares similares